Figure 3.
The three hit compounds I178, I288, and I942 were tested in a seven-point dose–response curve in the EPAC1-CNBD, 8-NBD-cAMP-binding assay.
Dose–response curves for HTS hits against EPAC1-CNBD.

The three hit compounds I178, I288, and I942 were tested in a seven-point dose–response curve in the EPAC1-CNBD, 8-NBD-cAMP-binding assay.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept